pSivida appoints new director

July 25, 2005 — pSivida Limited (NASDAQ: PSDV) announced the appointment of David Mazzo as a non-executive director of the company. Mazzo is president and CEO of Chugai Pharma USA, part of the Roche group of companies and a subsidiary of Chugai Pharmaceutical Company Limited (Japan), a global research-based pharmaceutical company. He is based in New Jersey.

Mazzo’s appointment follows pSivida’s recent NASDAQ listing and is intended to further assist pSivida’s strategy to increase its visibility in the US pharmaceutical and capital markets.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.